Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00963027 · ClinicalTrials.gov registry record · Phase 1
Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
A Phase 1 study, sponsored by United Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00963027 is a Phase 1 study that has completed, run by United Therapeutics. The registered enrollment target is 30 participants.
The verdict
NCT00963027, a Phase 1 study, has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of esomeprazole, a proton pump inhibitor, on treprostinil pharmacokinetics.
Interventions
- DRUG Esomeprazole
- DRUG Treprostinil diethanolamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00963027
The ClinicalTrials.gov registry entry for NCT00963027 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Esomeprazole is the first listed.
NCT00963027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00963027 about?
NCT00963027 is a clinical study titled "Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil". The purpose of this study is to evaluate the effect of esomeprazole, a proton pump inhibitor, on treprostinil pharmacokinetics.
What is the current status of trial NCT00963027?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-09. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00963027?
The interventions under investigation include: Esomeprazole (DRUG), Treprostinil diethanolamine (DRUG).
Who is sponsoring clinical trial NCT00963027?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.